IsoRay, Inc. (ISR) Stock: Headed For The Top On Build-Blu™ Release

IsoRay, Inc. (NYSEAMERICAN: ISR) is having an incredibly strong start to the trading session this morning after announcing the release of a new product. Of course, the news led to excitement among investors, sending the stock screaming for the top. Today, we’ll talk about: The Build-Blu™ system; what we’re seeing from ISR as a result; and … Read more

IsoRay (ISR) Stock: Gaining Big On Agreement

IsoRay, Inc. (NYSEAMERICAN: ISR) is having an overwhelmingly strong day in the market today, and for good reason. The company announced that it has entered into a manufacturing and supply agreement surrounding Cesium-131. Today, we’ll talk about the agreement, what we’re seeing from the stock, and what we’ll be watching for ahead. ISR Enters Manufacturing … Read more

Healthcare Stocks To Watch | MannKind Corporation (MNKD) | Aoxing Pharmaceutical Company (AXN) | IsoRay (ISR)

If you follow my writing here or elsewhere, you know that my favorite sector to follow is biotech. With that said, I was digging around the biotech space earlier today and found a few stocks that are well worth keeping an eye on. Here’s what I was able to dig up… MannKind Corporation Stock Is … Read more

IsoRay (ISR) Stock | When Will It Start Climbing Again?

IsoRay, Inc. (NASDAQ: ISR) IsoRay, has had an interesting week in the market thus far. After announcing that Cesium-131 was indeed effective in the treatment of cancer, the company went under attack by Adam Feuerstein; who discredited their press release and drove the stock price down. However, I’ve said a few times since then that … Read more